Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying ...

However, there are several ways to distinguish between the two disorders: Pityriasis alba can also be confused with vitiligo, ...

Vyne Therapeutics Inc ( (VYNE) ) has released its Q3 earnings. Here is a breakdown of the information Vyne Therapeutics Inc presented to its ...

Retinal, a derivative of vitamin A, works in various ways to improve the appearance of your skin. Here’s how to determine how ...

VYN201 Phase 2b vitiligo trial exceeds enrollment target; Expected to be fully enrolled in December 2024 with top-line results on track for ...

A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis ...

Thomas Bieber, University of Bonn, Germany, wasted no time in welcoming his colleagues from around the world to the ...

Investigators conducted a systemic review to summarize evidence regarding the use systemic Janus kinase inhibitors in patients with refractory nonsegmental vitiligo.

Research indicates elevated cardiovascular risk in vitiligo patients, underscoring the necessity for enhanced monitoring and ...

Incyte (Nasdaq:INCY) today reports 2024 third quarter financial results, and provides a status update on the Company’s clinical development portfolio. "In the third quarter of 2024, we delivered ...

White patches on your skin may be more than a cosmetic issue. Experts reveal how vitamin deficiencies, like B12 and D, ...

A breakthrough medication in vitiligo treatment that has been available in the U.S. for more than two years has finally been approved in Canada. Ruxolitinib, known by its brand name Opzelura, is a ...